| phagocytic efficiency of monocytes and macrophages obtained from sydney blood bank cohort members infected with an attenuated strain of hiv-1. | defective function of monocyte-derived macrophages contributes to hiv-1 pathogenesis. we found that phagocytosis of the opportunistic pathogens mycobacterium avium complex and toxoplasma gondii was impaired in monocytes obtained from individuals infected with wild-type strains of hiv-1 but generally not in monocytes collected over a 6-year period from sydney blood bank cohort (sbbc) members infected with nef/long terminal repeats (ltr) region-defective strains of hiv-1. however, longitudinal ana ... | 2003 | 14657753 |
| national atypical mycobacteria survey, 2000. | infections with atypical mycobacteria in australia during 2000 occurred at a rate of 1.8 cases per 100,000 population. the main sites of disease were the respiratory tract, soft tissue, and the lymphatics. the mycobacterium avium complex was the most common group of mycobacteria isolated from respiratory, lymphatic sites, and blood. the rapidly growing mycobacteria, predominantly the m. fortuitum-m. abscessus-m. chelonae group were the most common soft tissue infections. atypical mycobacteria we ... | 2003 | 12926733 |
| trends in incidence of aids illnesses in australia from 1983 to 1994: the australian aids cohort. | to assess time trends in incidence of aids illnesses in australia, a retrospective cohort of people diagnosed with aids from january 1, 1983 to december 31, 1994 in three hiv medicine units in sydney, melbourne, and perth was established. data on initial and subsequent aids illnesses were available for 2580 aids cases, or 45% of australian aids notifications over the study period. males represented 97.2% of the cohort, and hiv exposure category was homosexual contact for 89.9%. subcohorts were f ... | 1997 | 9377123 |
| prevalence of and risk factors for hiv-associated neuropathy in melbourne, australia 1993-2006. | the aim of the study was to describe the prevalence of and risk factors for hiv-associated sensory neuropathy (hiv-sn) in 2006 [the era of stavudine, didanosine and zalcitabine (dnrti)-sparing highly active antiretroviral therapy (haart)] and to compare our findings with data obtained in the same clinic in 1993 (pre-haart) and 2001 (frequent use of dnrti-containing haart). | 2007 | 17661844 |